Delivery Order SPE2DB24D2216-SPE2DB25FGPES
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,285.72 to AmerisourceBergen Drug Corp for the supply of Zyflo 600 mg tablets (120-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price terms with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a $4,755.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 600 mg Zyflo tablets. As the prime contractor, Amerisourcebergen will supply 120 tablets to the DLA under a contract starting on July 21, 2023 and concluding on July 24, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were identified. The DLA manages the Department of Defense's supply...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,115.29 firm fixed price delivery order is for the supply of 4565069779 - ZYFLO 600 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance that runs through July 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves...
- The Defense Logistics Agency awarded a delivery order valued at $12,869.29 to AmerisourceBergen Drug Corp for the supply of Zileuton ER 600 mg tablets (120-count units) on October 17, 2025. The contract utilizes a firm fixed-price structure with an ultimate completion date of October 20, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zileuton ER 600 mg tablets (120 count) with a ceiling value of $4,620.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by August 7, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- This is a $5,023.14 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILEUTON ER 600 MG TABLET 120S, a pharmaceutical product, with a performance period ending on July 1, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,566,066,604 Zileuton ER 600 MG tablets. The $3,866.13 firm fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen is providing these medications under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,725.03 to AmerisourceBergen Drug Corp for the supply of Zurzuvae 25 mg capsules (28-count packaging). The contract is classified as a non-competitive, firm fixed-price delivery order with a completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPESDelivery Order
The Defense Logistics Agency awarded a $46,601.78 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Zyflo 600 mg on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's DLA Troop Support Medical contract functions as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order for Zyflo, a leukotriene inhibitor used in respiratory and allergy treatment, exemplifies the company's role in supplying specialized medications to Defense Health Agency and U.S. Coast Guard healthcare programs through competitive federal procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.6k | 7/14/25 |